Dr. Andrew L. Pecora
Claim this profileHackensack University Medical Center
Studies Melanoma
Studies Skin Cancer
11 reported clinical trials
14 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
BRAF positive
2Skin Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Andrew L. Pecora is currently running
CDK4/6 Inhibitor
for Liposarcoma
This trial tests SPH4336, a chemotherapy pill, in patients with CDK4-positive liposarcomas. The drug works by blocking an enzyme that cancer cells need to grow, aiming to stop tumor growth.
Recruiting1 award Phase 2
Cemiplimab + Palbociclib
for Liposarcoma
This phase II trial compares the effect of treatment with palbociclib alone to treatment with palbociclib plus cemiplimab for treating patients with dedifferentiated liposarcoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Palbociclib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Cemiplimab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. The combination of these two drugs may be more effective in shrinking or stabilizing advanced dedifferentiated liposarcoma compared to palbociclib alone.
Recruiting1 award Phase 2
More about Andrew L. Pecora
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Andrew L. Pecora has experience with
- Nivolumab
- Pembrolizumab
- Cemiplimab
- Ipilimumab
- RP1
- Relatlimab
Breakdown of trials Andrew L. Pecora has run
Melanoma
Skin Cancer
Cancer
Cutaneous Melanoma
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew L. Pecora specialize in?
Andrew L. Pecora focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Andrew L. Pecora currently recruiting for clinical trials?
Yes, Andrew L. Pecora is currently recruiting for 5 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Andrew L. Pecora has studied deeply?
Yes, Andrew L. Pecora has studied treatments such as Nivolumab, Pembrolizumab, Cemiplimab.
What is the best way to schedule an appointment with Andrew L. Pecora?
Apply for one of the trials that Andrew L. Pecora is conducting.
What is the office address of Andrew L. Pecora?
The office of Andrew L. Pecora is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.